Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments – a Swedish national registry study
Comorbidity burden and patterns differed between HCC treatment groups, with CCI-P significantly associated with mortality. Preoperative attention to cardiovascular disease is important, but other comorbid conditions may require vigilance. Given the higher prevalence of comorbidities in ablation and resection patients, efforts to optimize comorbidity in these groups may be warranted.
Authors
- Fredrik O. Åberg (ORCID: https://orcid.org/0000-0002-3833-0705)
- Helena Taflin (ORCID: https://orcid.org/0000-0002-8795-5250)
- Juan Vaz (ORCID: https://orcid.org/0000-0002-7232-8000)
- Malin Sternby Eilard (ORCID: https://orcid.org/0000-0002-5274-7726)
- Madeleine Helmersson
- Magnus Rizell (ORCID: https://orcid.org/0000-0001-9791-5247)
Institutions
- University of Helsinki (FI)
- Helsinki University Hospital (FI)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Scandinavian Journal of Gastroenterology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1080/00365521.2025.2487539
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35